|34.78||-2.41 / -6.48%|
Data as of 4:00pm ET
|34.78||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +0.63% increase from the last price of 34.78.
The current consensus among 3 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.